JDRF and Sanofi-aventis Join Forces in Search of Cure for Type 1 Diabetes

Sanofi-aventis and the Juvenile Diabetes Research Foundation (JDRF) announced a unique partnership to develop therapeutic treatments for people with type 1 diabetes at different stages of the disease – both those living with the disease and the newly diagnosed – as well as preventing diabetes in those at risk… Read more

JDRF Funds Clinical Trial to Test Pig Islet Cells

The Juvenile Diabetes Research Foundation announced today that it is partnering with Living Cell Technologies (LCT), a New Zealand-based biotechnology company focused on developing cell based therapeutics, in a Phase II clinical trial to study the safety and effectiveness of transplanting encapsulated insulin-producing cells from pigs as a treatment for type 1 diabetes with significant hypoglycemia unawareness…. Read more

Successful First Trial for Artificial Pancreas

The new artificial pancreas system developed at Boston University was able to maintain near-normal glucose levels without causing hypoglycemia in a small group of type 1 diabetic patients in the first clinical trial conducted at Massachusetts General Hospital…. Read more

Researchers Cure Type 1 Diabetes in Mice

Using a sophisticated nanotechnology-based “vaccine,” researchers were able to successfully cure mice with type 1 diabetes and slow the onset of the disease in mice at risk for the disease. The study, co-funded by the Juvenile Diabetes Research Foundation, provides new and important insights into understanding how to stop the immune attack that causes type 1 diabetes… Read more

The Regeneration of Beta Cells

A new study shows alpha cells in the pancreas, the cells which secrete the hormone glucagon, can regenerate themselves into insulin-producing beta cells… Read more

Subscribe to our Newsletter

Hide me